medRxiv 预印本· Sharew, N. T., Clark, S. R., Arolt, V., Brockmoller, J., Chen, C.-H., Domschke, K., Hall-Flavin, D. K., Illi, A., Kampman, O., Leinonen, E., Liou, Y.-J., Mushiroda, T., Stingl, J. C., Benjaponpitak, A., Mahasirimongkol, S., Wang, L., Kato, M., Liu, Y.-L., Bobo, W. V., Tsai, S.-J., Kubo, M., Weinshilboum, R. M., Mrazek, D. A., Biernacka, J. M., Baune, B. T., Schubert, K. O., Amare, A. T. ·· 28 天前AI 评分36
基于神经递质的多基因评分与重度抑郁症患者抗抑郁治疗结局的关联
Association of neurotransmitter-based polygenic scores with antidepressant treatment outcomes in patients with major depressive disorder
AI 导读
研究构建了5-羟色胺能(5228个变异)、GABA能(4103个)、多巴胺能(7061个)和谷氨酸能(5690个)多基因评分,并在ISPC与PGRN-AMPS两个SSRI治疗队列中评估其与疗效的关联。
来源:medRxiv 预印本 · medrxiv.org